W. Weiss

DAV131A Protects Hamsters from Lethal Clostridioides difficile Infection Induced by Fluoroquinolones

J. de Gunzburg, A. Andremont, F. Mentré, 2019, Antimicrobial Agents and Chemotherapy.

In vitro and in vivo characterization of novel 8-methoxy derivatives of chlortetracycline.

D. Loebenberg, F. Menzel, A. Cacciapuoti, 1987, The Journal of antibiotics.

Antibiotic-Induced Dysbiosis Predicts Mortality in an Animal Model of Clostridium difficile Infection

J. de Gunzburg, A. Andremont, P. Hugon, 2018, Antimicrobial Agents and Chemotherapy.

Protection of Hamsters from Mortality by Reducing Fecal Moxifloxacin Concentration with DAV131A in a Model of Moxifloxacin-Induced Clostridium difficile Colitis

J. de Gunzburg, A. Andremont, T. Nguyen, 2017, Antimicrobial Agents and Chemotherapy.

DAV132, an Adsorbent-Based Product, Protects the Gut Microbiome and Prevents Clostridium difficile Infections during Moxifloxacin Treatments

J. Doré, S. Kennedy, F. Levenez, 2015 .

In Vivo Assessment of SMT19969 in a Hamster Model of Clostridium difficile Infection

R. Vickers, M. Pulse, W. Weiss, 2014, Antimicrobial Agents and Chemotherapy.

DAV131, AN ORAL ADSORBENT-BASED PRODUCT, FULLY PROTECTS HAMSTERS AGAINST MOXIFLOXACIN-INDUCED CLOSTRIDIUM DIFFICILE LETHAL INFECTION

A. Andremont, E. Chachaty, T. Murphy, 2012 .